NL-OMON20325
Completed
Not Applicable
eoadjevant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinomas or squamous cell carcinomas of the esophagus.
/A0 sites350 target enrollmentTBD
ConditionsEsophageal cancer.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Esophageal cancer.
- Sponsor
- /A
- Enrollment
- 350
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 \< age \< 75 year, surgical resectable T2\-3, N0\-1, M0, tumour length longitudinal \<8cm and radial \<5cm, no invasion tracheobronchial tree, tumour must not extend more than 2 cm into the stomach, ECOG 0\-2\.
Exclusion Criteria
- •T1N1, T1N0, past or current history of malignancy other than entry diagnosis, previouw chemotherapy or radiotherapy, MI in last 6 months, congestive heart failure or arrhythmia requiring medication, neurotoxicity grade \>1, inadequate caloric and or fluid intake, weight loss 10%.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
T4 Oesophageal Resection.Esophageal carcinoma, Esophagectomy, Chemoradiotherapy, T4 tumorNL-OMON25753Academic Medical Center (AMC), Department of Surgery30
Completed
Not Applicable
eoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinomas or squamous cell carcinomas of the esophagusISRCTN80832026Erasmus Medical Center, Department of Medical Oncology (Netherlands)350
Active, not recruiting
Phase 1
clinical study to evaluate the efficacy of a two drug combination versus a single drug therapy in the treatment of locally advanced rectal cancer.locally advanced rectal cancerMedDRA version: 17.0Level: PTClassification code 10038050Term: Rectal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: PTClassification code 10038049Term: Rectal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2006-006532-21-DEEORTC1,094
Active, not recruiting
Not Applicable
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancerRectal cancerLocally Advanced Rectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12608000403336Australasian Gastro-Intestinal Trials Group (AGITG)1,090
Active, not recruiting
Phase 1
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (PETACC-6) - PETACC-6locally advanced rectal cancerMedDRA version: 9.1Level: LLTClassification code 10038050Term: Rectal cancer stage IIIMedDRA version: 9.1Level: LLTClassification code 10038049Term: Rectal cancer stage IIEUCTR2006-006532-21-FREORTC1,090